ALFA Filings
Every announcement, straight from the exchange
Every Natco Pharma regulatory approval announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements
Natco Pharma received tentative U.S. FDA approval for Olaparib tablets. The reference drug Lynparza reported USD 1.4 billion in U.S. sales.
Natco Pharma and Lupin received U.S. FDA approval for Eribulin Mesylate Injection. The product targets a USD 43.7 million market for metastatic breast cancer treatment.